4 ms·
To be even more precise, ineffective in hospitalized patients. UMN has done another study for "outpatient" (that is, not hospitalized) treatment and sent the re
by lbeltrame 6y ago
To be even more precise, ineffective in hospitalized patients. UMN has done another study for "outpatient" (that is, not hospitalized) treatment and sent the results for review.
I'm not expecting any different results than from this one, but we'll know soon enough.
The RECOVERY study is also studying azithromycin, a drug commonly administered with HCQ when used against this disease. It would be ironic if that one proves to be effective (study is still ongoing).
- sdiq 6y agoI have been following both the UMN study and this Recovery Trial. I realize, in between whether HCQ prevents SARS-CoV2 and whether the same helps severe hospitalized cases, we have another question of whether it works as early treatment. The first question seem to have been well answered by Dr Boulware's team. The third one seem to also have been definitively been answered by the Recovery team. However, as yet, other than people taking sides in what has now become something of a religious war, I am yet to come across a study that definitively answers this question of whether HCQ can work when given as early treatment. Most of the Covid-19 related literature that is so far accessible seem to be of a very poor quality. But, still, I am hoping we will have properly conducted and sufficiently powered randomized control trials in due course that should answer most of these questions as well as find out a good way out of this quagmire.
- rsynnott 6y agoAlso been done to some extent: https://blogs.sciencemag.org/pipeline/archives/2020/06/04/hydroxychloroquine-for-avoiding-infection https://blogs.sciencemag.org/pipeline/archives/2020/06/04/hy... That study shows nothing. I assume there'll be others along in time.